BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 29055225)

  • 1. Generation and characterization of a human iPSC line SANi005-A containing the gray platelet associated heterozygous mutation p.Q287* in GFI1B.
    Hansen M; Varga E; Wüst T; Mellink C; van der Kevie-Kersemaekers AM; Marneth AE; von Lindern M; van der Reijden B; van den Akker E
    Stem Cell Res; 2017 Dec; 25():34-37. PubMed ID: 29055225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of a human iPSC line (MUSIi007-A) from peripheral blood of normal individual using Sendai viral vectors.
    Potirat P; Wattanapanitch M; Kheolamai P; Issaragrisil S
    Stem Cell Res; 2018 Oct; 32():43-46. PubMed ID: 30172906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of Mucopolysaccharidosis type II (MPS II) human induced pluripotent stem cell (iPSC) line from a 7-year-old male with pathogenic IDS mutation.
    Varga E; Nemes C; Bock I; Varga N; Fehér A; Kobolák J; Dinnyés A
    Stem Cell Res; 2016 Nov; 17(3):463-465. PubMed ID: 27789394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of Mucopolysaccharidosis type II (MPS II) human induced pluripotent stem cell (iPSC) line from a 1-year-old male with pathogenic IDS mutation.
    Varga E; Nemes C; Bock I; Varga N; Fehér A; Dinnyés A; Kobolák J
    Stem Cell Res; 2016 Nov; 17(3):482-484. PubMed ID: 27789399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of Mucopolysaccharidosis type II (MPS II) human induced pluripotent stem cell (iPSC) line from a 3-year-old male with pathogenic IDS mutation.
    Varga E; Nemes C; Bock I; Varga N; Fehér A; Kobolák J; Dinnyés A
    Stem Cell Res; 2016 Nov; 17(3):479-481. PubMed ID: 27789398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of human induced pluripotent stem cell (iPSC) line from an unaffected female carrier of Mucopolysaccharidosis type II (MPS II) disorder.
    Varga E; Nemes C; Kovács E; Bock I; Varga N; Fehér A; Dinnyés A; Kobolák J
    Stem Cell Res; 2016 Nov; 17(3):514-516. PubMed ID: 27789401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of human erythroblast-derived iPSC line using episomal reprogramming system.
    Varga E; Hansen M; Wüst T; von Lindern M; van den Akker E
    Stem Cell Res; 2017 Dec; 25():30-33. PubMed ID: 29040913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of human induced pluripotent stem cells (EURACi001-A, EURACi002-A, EURACi003-A) from peripheral blood mononuclear cells of three patients carrying mutations in the CAV3 gene.
    Meraviglia V; Benzoni P; Landi S; Murano C; Langione M; Motta BM; Baratto S; Silipigni R; Di Segni M; Pramstaller PP; DiFrancesco D; Gazzerro E; Barbuti A; Rossini A
    Stem Cell Res; 2018 Mar; 27():25-29. PubMed ID: 29304398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation and characterization of a human iPSC line SANi006-A from a Gray Platelet Syndrome patient.
    Aarts CEM; Varga E; Webbers S; Geissler J; von Lindern M; Kuijpers TW; van den Akker E
    Stem Cell Res; 2021 Aug; 55():102443. PubMed ID: 34237592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of a human control PBMC derived iPS cell line TUSMi001-A from a healthy male donor of Han Chinese genetic background.
    Wang Y; Zhang Y; Zhang J; Lu J; Yang C; Zhao J; Li G; Liu Z; Lei Y
    Stem Cell Res; 2017 Dec; 25():22-25. PubMed ID: 29035843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a human induced pluripotent stem cell (iPSC) line from a 64year old male patient with multiple schwannoma.
    Zhang S; Lv Z; Hu Y; Liu L; Gong W; Li Q; Wu H
    Stem Cell Res; 2017 Mar; 19():49-51. PubMed ID: 28413006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of induced pluripotent stem cells (iPSCs) from an infant with catecholaminergic polymorphic ventricular tachycardia carrying the double heterozygous mutations A1855D in RyR2 and Q1362H in SCN10A.
    Zhang Y; Li A; Huang CL; Wang G; Wang D
    Stem Cell Res; 2019 Aug; 39():101509. PubMed ID: 31382203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation and characterization of human iPSC line MML-6838-Cl2 from mobilized peripheral blood derived megakaryoblasts.
    Hansen M; Varga E; Wüst T; Brouwer N; Beauchemin H; Mellink C; van der Kevie-Kersemaekers AM; Möröy T; van der Reijden B; von Lindern M; van den Akker E
    Stem Cell Res; 2017 Jan; 18():26-28. PubMed ID: 28395797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral blood derived induced pluripotent stem cells (iPSCs) from a female with familial hypertrophic cardiomyopathy.
    Ross SB; Fraser ST; Bagnall RD; Semsarian C
    Stem Cell Res; 2017 Apr; 20():76-79. PubMed ID: 28395744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation and characterization of a control and patient-derived human iPSC line containing the Hermansky Pudlak type 2 (HPS2) associated heterozygous compound mutation in AP3B1.
    Aarts CEM; Karampini E; Wüst T; Webbers S; Varga E; Geissler J; Voorberg J; von Lindern M; Bierings R; van den Akker E; Kuijpers TW
    Stem Cell Res; 2021 Jul; 54():102444. PubMed ID: 34182253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Derivation of human induced pluripotent stem cell (iPSC) line from a 79year old sporadic male Parkinson's disease patient.
    Zhang S; Liu L; Hu Y; Lv Z; Li Q; Gong W; Sha H; Wu H
    Stem Cell Res; 2017 Mar; 19():43-45. PubMed ID: 28413004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of human induced pluripotent stem cell (iPSC) line from a 60year old female patient with multiple schwannoma.
    Zhang S; Lv Z; Liu Y; Li Q; Gong W; Liu L; Wu H
    Stem Cell Res; 2017 Mar; 19():31-33. PubMed ID: 28413001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation and characterization of human iPSC lines SANi001-A and SANi002-A from mobilized peripheral blood derived megakaryoblasts.
    Hansen M; Varga E; Wüst T; Mellink C; van der Kevie-Kersemaekers AM; von Lindern M; van den Akker E
    Stem Cell Res; 2017 Dec; 25():42-45. PubMed ID: 29055227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of an induced pluripotent stem cell line (CSC-44) from a Parkinson's disease patient carrying a compound heterozygous mutation (c.823C>T and EX6 del) in the PARK2 gene.
    Marote A; Pomeshchik Y; Goldwurm S; Collin A; Lamas NJ; Pinto L; Salgado AJ; Roybon L
    Stem Cell Res; 2018 Mar; 27():90-94. PubMed ID: 29353703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of induced pluripotent stem cells (iPSCs) from a Bernard-Soulier syndrome patient carrying a W71R mutation in the GPIX gene.
    Lopez-Onieva L; Montes R; Lamolda M; Romero T; Ayllon V; Lozano ML; Vicente V; Rivera J; Ramos-Mejía V; Real PJ
    Stem Cell Res; 2016 May; 16(3):692-5. PubMed ID: 27346198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.